Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Immuno-Deoxy is an oral multi-ingredient dietary supplement and nutraceutical developed by Muno-Vax Biotechnologies in conjunction with Natstim as an immune support product for people with severely compromised immune systems. The formulation contains a patented antioxidant and micronutrient complex including vitamin E succinate, vitamin C, zinc, selenium, alpha-lipoic acid, and coenzyme Q10, and is marketed for supportive use during immune compromise associated with inherited conditions, medical procedures, poor nutrition, aging, physical or mental stress, postoperative recovery, and after radiation or chemotherapy. Its claimed mechanism is nonspecific nutritional and antioxidant support of immune function rather than a defined pharmaceutical target-based mechanism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Immuno-Deoxy.